CULS Conversion and Additional Listing
Neuronetics selected by World Economic Forum as 2011 Technology Pioneer
TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING
To keep up to date with news from this category use our ![]()
PharmaGap Announces Closing of First Tranche of Private Placement
Ottawa, Ontario/ August 30, 2010 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") announced today that it has completed the initial tranche of an offering of equity units (the "Units")...
THERMOGENESIS ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE ON NASDAQ CAPITAL MARKET AUGUST 27, 2010
(RANCHO CORDOVA, CA), August 26, 2010--ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said it has filed a Certificate of Amendment...
Achillion Announces Private Placement of $50 Million
NEW HAVEN, Conn., Aug. 18, 2010 -- Achillion Pharmaceuticals, Inc., (Nasdaq:ACHN) a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced...
THERMOGENESIS ANNOUNCES STOCKHOLDER AUTHORIZATION OF REVERSE SPLIT
(RANCHO CORDOVA, CA), August 11, 2010--ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its Board of Directors has...
TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING
Malvern, PA, August 10, 2010 - TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new...
PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010
lRVINE, CA, June 01, 20 I 0 - PRO-DEX, INC. (NASDAQ: PDEX) today announced that its Board of Directors has detennined to effect a reverse split of the Company's common stock pursuant to authority previously granted...